158 related articles for article (PubMed ID: 36281939)
1. Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cells.
Yagi C; Tatsuoka J; Sano E; Hanashima Y; Ozawa Y; Yoshimura S; Yamamuro S; Sumi K; Hara H; Katayama Y; Yoshino A
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281939
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effects of perampanel in malignant glioma cells.
Tatsuoka J; Sano E; Hanashima Y; Yagi C; Yamamuro S; Sumi K; Hara H; Takada K; Kanemaru K; Komine-Aizawa S; Katayama Y; Yoshino A
Oncol Lett; 2022 Dec; 24(6):421. PubMed ID: 36284648
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine.
Itoh K; Taniguchi R; Matsuo T; Oguro A; Vogel CFA; Yamazaki T; Ishihara Y
Neurosci Lett; 2019 Aug; 708():134363. PubMed ID: 31276728
[TBL] [Abstract][Full Text] [Related]
4. AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
Lange F; Weßlau K; Porath K; Hörnschemeyer MF; Bergner C; Krause BJ; Mullins CS; Linnebacher M; Köhling R; Kirschstein T
PLoS One; 2019; 14(2):e0211644. PubMed ID: 30716120
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy.
Kanemura H; Sano F; Ohyama T; Aihara M
Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427
[TBL] [Abstract][Full Text] [Related]
6. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
Tumay Y; Altun Y; Ekmekci K; Ozkul Y
Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of lenalidomide in malignant glioma cell lines.
Hanashima Y; Sano E; Sumi K; Ozawa Y; Yagi C; Tatsuoka J; Yoshimura S; Yamamuro S; Ueda T; Nakayama T; Hara H; Yoshino A
Oncol Rep; 2020 May; 43(5):1580-1590. PubMed ID: 32323826
[TBL] [Abstract][Full Text] [Related]
8. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.
Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F
CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751
[TBL] [Abstract][Full Text] [Related]
11. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy.
Chonan M; Saito R; Kanamori M; Osawa SI; Watanabe M; Suzuki H; Nakasato N; Tominaga T
Neurol Med Chir (Tokyo); 2020 Jan; 60(1):37-44. PubMed ID: 31748440
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms.
Chen Y; Tsai YH; Tseng SH
J Neurooncol; 2012 Aug; 109(1):23-33. PubMed ID: 22528797
[TBL] [Abstract][Full Text] [Related]
13. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
14. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
[TBL] [Abstract][Full Text] [Related]
15. Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro.
Knüpfer MM; Pulzer F; Schindler I; Hernaíz Driever P; Knüpfer H; Keller E
Anticancer Res; 2001; 21(1A):347-51. PubMed ID: 11299760
[TBL] [Abstract][Full Text] [Related]
16. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
Stepanova D; Beran RG
Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
[TBL] [Abstract][Full Text] [Related]
17. Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma.
Eckert M; Klumpp L; Huber SM
Cell Physiol Biochem; 2017; 44(4):1591-1605. PubMed ID: 29212069
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of anti-epileptic drugs-an internet study.
Wieshmann UC; Baker G
Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment with clinically relevant valproate, carbamazepine, oxcarbazepine, topiramate, lamotrigine and levetiracetam on ovarian folliculogenesis in young rats.
Cansu A; Gurgen SG; Demirhan YN; Ozkan Kart P; Yildirim M; Alver A; Yeni Lmez E; Sönmez FM
Epilepsy Res; 2022 Aug; 184():106966. PubMed ID: 35763982
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effect of Perampanel and Temozolomide in Human Glioma Cell Lines.
Salmaggi A; Corno C; Maschio M; Donzelli S; D'Urso A; Perego P; Ciusani E
J Pers Med; 2021 May; 11(5):. PubMed ID: 34068749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
